Quick ReadPlain-language overview · read this first
Tokyo Ohka Kogyo is a Japanese company that supplies chip fabs worldwide. This report rates it as "Watch": it is a high-quality company, but the current price is not attractive, so the better approach is to wait for a cheaper entry point.
Its core product is photoresist, a specialized material used repeatedly in semiconductor manufacturing, and Tokyo Ohka Kogyo is one of the world's leading suppliers. The business has some of the traits of a consumables model: customers must keep buying as long as they produce chips, and once they use its materials, switching to another supplier requires requalification and may hurt yield, so customers rarely switch lightly. This hard-to-replicate know-how is its biggest asset.
Business has indeed been strong over the past year, and earnings reached a record high. The report flags 2 issues. First, about 2 billion yen of last year's profit was one-off and will not recur every year, so that level should not be extrapolated. Second, the company is spending heavily on new facilities, meaning a sizable portion of accounting profit is being reinvested into capacity expansion, and the cash that can truly be pocketed is much lower than the profit figure suggests.
On valuation, based on its current earnings, buying the whole company would take about 35 years to pay back, which the report views as clearly expensive. Another risk is customer concentration: TSMC alone contributes more than 30% of revenue, so any change at this major customer would have a large impact. The report's ideal buying range is 4000 to 5000 yen, but the stock has already risen to about 9700 yen, meaning investors have paid in advance for many years of future good news.
Overall, the report sees this as a good company worth following for the long term, but not a bargain that investors need to rush into today.
The above is only a plain-language explanation of this report and is not investment advice. The stock market involves risk; invest with caution.
LeadTokyo Ohka Kogyo (TOK) is a key global supplier of semiconductor photoresists and high-purity chemicals, serving advanced-node foundries including TSMC. FY2025 revenue and profit attributable to owners reached record highs, the balance sheet remained in a net cash position, and the equity ratio was close to 68%, but free cash flow is still well below accounting profit during a heavy capex cycle. Research rating Watch: a high-quality semiconductor materials compounder, yet at roughly ¥9,700 the stock is already near the upper end of an optimistic valuation range and lacks a sufficient margin of safety.
Bottom Line First
If I assess Tokyo Ohka Kogyo as an ownership stake to be held for more than ten years, my current conclusion is: the rating is “Watch.” The issue is not that the company is poor. On the contrary, it looks more like a good business and a good company, but not an inexpensive stock at today’s price. As of 2026-06-09, Yahoo! Japan search results showed Tokyo Ohka Kogyo’s closing price at roughly ¥9,700/share. Based on about 119.88 million non-treasury shares at the end of 2025, its equity market value was about ¥1.16 trillion. Using FY2025 diluted EPS of ¥278.21 and BPS of ¥1,898.90, the current price implies roughly 34.9x trailing PE and 5.1x PB. Even using the company’s FY2026 profit attributable to owners guidance of ¥35.0bn, forward PE is still around 33x. For a semiconductor materials company with real technical barriers, but whose freely distributable cash flow remains compressed by expansion, this price already discounts a fairly optimistic growth path.
More specifically, Tokyo Ohka Kogyo is attractive because it is a major global player in semiconductor photoresists and high-purity chemicals. In its 2026 official materials, the company still describes itself as a market leader in the photoresist industry, while continuing to expand capabilities in EUV, advanced packaging, and high-purity chemicals. FY2025 results were indeed very strong, with revenue, operating profit, profit attributable to owners, and EBITDA all reaching record highs. The problem is that 2025 profit improvement included about ¥2.0bn of one-off inventory recognition gains, while net profit was also lifted by nonrecurring gains related to the transfer of the equipment business. At the same time, 2025-2027 is a heavy capital expenditure phase. Capex was ¥28.7bn in 2025 and is planned to rise further to ¥35.8bn in 2026, while working capital is also consuming cash. In other words, this is an excellent business, but buying today does not give you an obviously cheap claim on future cash flows.
Conclusion Summary
| Item | Judgment |
|---|---|
| Investment rating | Watch |
| Core judgment | Company quality is high, its industry position is strong, and long-term demand is supported; however, the current price is already close to the upper end of my optimistic valuation range, leaving insufficient margin of safety. |
| Does the current price offer a margin of safety? | No |
| Better suited investors | Long-term investors who already track the semiconductor materials chain and are willing to wait for a better price; less suitable for ordinary investors who are conservative but want to initiate a position immediately |
| Biggest uncertainties | Durability of AI-driven advanced-node and advanced-packaging demand; whether EUV and next-generation photoresist roadmaps can deliver; excessive concentration in TSMC and Taiwan |
From the perspective of “would I be willing to hold this if the market closed for five years,” my answer is: at the right price, yes; at the current price, I would not add new capital. That is the central judgment of this report.
Business, Industry, and Competition
Tokyo Ohka Kogyo’s business can be simplified into one sentence: it continuously supplies electronic materials and high-purity chemicals with high technical thresholds and strong customer qualification attributes to global wafer fabs and the semiconductor manufacturing chain. Accounting-wise, the company reports one business segment, but its external management view divides revenue into three parts: electronic functional materials, high-purity chemicals, and others. In FY2025, revenue from the three categories was approximately ¥124.7bn, ¥109.4bn, and ¥2.9bn, respectively, meaning electronic functional materials accounted for about 52.6% and high-purity chemicals for about 46.2%. The company’s FY2025 results presentation also stated clearly that growth was mainly driven by generative AI-related demand, PC replacement, and a higher share of high-value-added advanced materials.
The customers of this business are not end consumers. They are a very small number of semiconductor manufacturers and related supply-chain customers with extremely high technical requirements. Tokyo Ohka Kogyo’s 2025 securities report disclosed that sales to TSMC as a single customer reached ¥79.6bn, about 33.6% of total revenue. By region, Taiwan accounted for about 36.1% of revenue, while Japan, China, South Korea, and the United States also held important shares. The company also disclosed that standalone sales at its Taiwan subsidiary reached ¥86.5bn, making it extremely important within the group. For owners, this means the business is not “diversified small-ticket recurring payments.” It is an industrial consumables model that is highly recurring, but also highly concentrated by customer.
Revenue repeatability comes from the fact that these materials are continuously consumed in wafer manufacturing, rather than equipment sold once and done. But this is still not SaaS-style subscription revenue with high visibility. In its revenue recognition notes, Tokyo Ohka Kogyo says directly that the company has no significant contracts with expected terms exceeding one year. This means its “recurrence” is built mainly on customer qualification and continued wafer starts, rather than order backlog. That distinction matters. It explains why the company can grow over the long term, while still fluctuating in the short and medium term with semiconductor capex and utilization.
On cost structure, Tokyo Ohka Kogyo is not a typical asset-light software company. It is a high-end materials company where R&D, quality control, manufacturing capex, and working capital are all substantial. In FY2025, the company disclosed R&D spending of ¥15.7bn, capex of ¥28.7bn, and depreciation of ¥8.8bn. In 2026, it plans to raise those three figures to ¥18.2bn, ¥35.8bn, and ¥11.3bn, respectively. From an owner’s perspective, this means growth quality is good, but the model is not one where growth requires ever less cash. It is closer to a hybrid model of “high-return R&D plus cyclical heavy investment in capacity expansion.”
At the industry level, I would define it as a high-quality track with long-term appeal, short-term cyclicality, and extremely fast technical iteration. In its spring 2025 forecast, WSTS expected the global semiconductor market to continue growing in 2026. Tokyo Ohka Kogyo itself raised its medium-term plan in February 2026, citing faster-than-previously-expected growth in demand for generative AI semiconductors. This shows the broad industry direction remains favorable. But the company’s annual report also lists industry cycle fluctuations, foreign exchange, R&D, intellectual property, raw materials, and regulation as key risks, reminding investors not to treat semiconductor materials as a risk-free asset with linear growth.
On competition, the most important names to watch are Shin-Etsu Chemical, JSR, the Fujifilm electronic materials system, Sumitomo Chemical, and other Japanese and Korean suppliers in more specialized materials categories. Reuters reported that JSR sees local co-development with customers in Taiwan as an important move to catch up with TOK and Shin-Etsu. Another Reuters report showed that Shin-Etsu Chemical announced in 2024 that it would invest about ¥83bn to build a new chip materials plant for lithography materials and other products. In other words, Tokyo Ohka Kogyo is not operating in a monopoly industry where no one can disturb it. It is in an industry where a small number of strong players invest heavily, stay close to customer iteration, and remain in a continuous arms race.
If the only question is “is this a business I can understand,” my answer is: economically, yes; technically, it has depth. I can clearly understand how it makes money, why customers keep purchasing, and why qualification barriers matter. But it would be dishonest to claim that every chemical route, EUV formulation, and next-generation photoresist mechanism sits fully inside my circle of competence. Therefore, I give its business understandability a score of 4/5 and the industry’s industry attractiveness a score of 4/5. It is a good company in a good industry, but not a perfect business that requires no concern about technology substitution or capital expenditure.
Moat, Management, and Capital Allocation
Tokyo Ohka Kogyo’s moat is not consumer brand power or network effects. It mainly lies in technical accumulation, customer qualification, manufacturing consistency, global local-service capability, and long-term R&D organization capability. The company’s official materials emphasize its “world-leading microprocessing and high purity technology.” In 2026, it also entered into a strategic investment and joint development partnership with Irresistible Materials to strengthen a new EUV resist platform beyond its existing CAR and MOR offerings. FY2025 results materials show that the company has already provided a CAR, SMR, and MOR “full lineup” around EUV, while continuing to advance “Beyond EUV” R&D. For advanced-node materials, the question is not simply “can you make it.” The real question is whether you can manufacture it stably at volume, enter the customer’s process, and deliver yield. That is exactly where TOK is strong.
Breaking down the moat item by item, my judgment is as follows. Brand advantage: strong among industrial customers, almost absent in consumer mindshare, making it a technical brand rather than a mass-market brand. Cost advantage: present, but not the core; TOK wins more through performance and qualification than through the lowest price. Scale advantage: medium to strong; the company has long been one of the important global suppliers of photoresist and continues to build presence in Japan, South Korea, Taiwan, the United States, and Europe. Network effects: essentially none. Switching costs: strong, because once photoresists and high-purity chemicals enter advanced processes, replacement means requalification, potential yield risk, and losses from line disruption. Channel advantage: medium to strong, since localized manufacturing and application support are crucial. Patent/regulatory/quality barriers: strong; the annual report clearly discloses that the company owns substantial intellectual property and manages licensing. Data advantage: not obvious. Corporate culture/operating capability: relatively strong; the company puts a thorough customer perspective and long-term R&D organization capability at the center. Capital allocation capability: moderately positive, with shareholder-return discipline and moves in capacity expansion and M&A, but whether those investments convert into sustained free cash flow still needs to be watched.
I believe this moat is overall stable to slightly widening, especially in advanced packaging, high-purity chemicals, and the global local-service network. But at the leading edge of EUV materials, it remains a moat that must keep widening, otherwise it will narrow. The difficulty for competitors trying to replicate TOK’s position is not any single technology point. It is the combined capability of “technology plus customer qualification plus global delivery plus process co-development plus quality consistency.” The replication threshold is visible from capex alone. TOK’s current projects include a new high-purity chemicals line in Aso, Kumamoto, for about ¥13bn; an inspection building in Incheon for about ¥7bn; the “world’s largest photoresist manufacturing building” under construction in Koriyama for more than ¥20bn; and a high-purity chemicals manufacturing building in Pyeongtaek for about ¥12bn. Shin-Etsu Chemical is also investing about ¥83bn in a new materials plant. This means replication cycles are usually measured in years, while replication capital is measured in several billion to tens of billions of yen.
On pricing power, I would call it “moderately strong” rather than “extremely strong.” Tokyo Ohka Kogyo’s 2025 operating profit bridge shows that foreign exchange changes and price adjustments together contributed about ¥1.6bn, indicating that the company is not powerless to raise prices when inflation and supply-demand conditions improve. But materials pricing is inseparable from customer processes, yield, and competitive dynamics. Real pricing power comes from “high replacement cost plus high performance requirements,” not from unilateral price hikes.
Can the company remain profitable in an economic downturn? The historical answer is: yes, but profit will fluctuate meaningfully. In the 2023 industry correction, Tokyo Ohka Kogyo’s revenue fell from ¥175.4bn to ¥162.3bn, and profit attributable to owners fell from ¥19.7bn to ¥12.7bn, but operating cash flow was still ¥17.2bn and the equity ratio remained 72.9%. So this is not a “noncyclical company,” but in the latest downcycle it demonstrated resilience by staying profitable, retaining cash flow, and avoiding excessive bleeding.
On management, my assessment is: credible and rational, though not yet an extremely strong owner-operator style. The positives are that the company has continued to raise medium-term targets, set a DOE 4% shareholder return policy, repurchased shares at relatively low prices, increased the ratio of outside directors, transitioned to a company with audit and supervisory committee, and maintained high board attendance. In addition, it did not continue its former takeover defense measures in 2025, which is relatively shareholder-friendly. The caveat is that management share ownership exists but is not very high. For example, President Nariichi Junaki holds about 110,000 shares, while several core internal directors hold 55,000 shares, 51,000 shares, 29,000 shares, and 17,000 shares, respectively. This gives them some skin in the game, but it is not a structure where interests are tightly bound at the controlling-shareholder level.
On capital allocation, I give a mildly positive assessment. The company’s medium-term plan is clear: cumulative EBITDA of about ¥190bn, of which about ¥76bn will go to capex, more than ¥20bn+ to growth investment, and more than ¥28bn+ to shareholder returns, with emphasis on DOE 4.0% and “flexible buybacks.” More importantly, based on the amounts and share counts disclosed for the two recent buyback programs, the average repurchase price was roughly ¥3,500-3,700/share, far below the current ¥9,700. That is much more rational than companies that buy back aggressively at highs to dress up EPS. On the other hand, the 2025 full acquisition of Germany’s micro resist technology GmbH appears strategically reasonable because it should strengthen European customer responsiveness and the technology portfolio, but whether it truly creates per-share value still needs two to three years of validation. Overall, I give Tokyo Ohka Kogyo a moat strength score of 4/5 and a management and capital allocation score of 3/5.
Financial Quality
Start with the five-year main table. Revenue, net profit, operating cash flow, ROE, equity ratio, cash equivalents, and per-share data in the table mainly come from the 2021-2025 consolidated financial indicators in the company’s 96th Annual Securities Report. EBITDA, capex, depreciation, and R&D spending for 2024-2025 come from the FY2025 results presentation. Some margins and cash conversion metrics in the table are calculated from the same source data.
| Year | Revenue | Profit attributable to owners | Net margin | Operating cash flow | CFO/net profit | ROE | Equity ratio | Ending cash equivalents | Notes |
|---|---|---|---|---|---|---|---|---|---|
| 2021 | 140.1 | 17.7 | 12.7% | 19.8 | 1.11x | 11.5% | 71.7% | 41.5 | Cycle upswing |
| 2022 | 175.4 | 19.7 | 11.2% | 19.0 | 0.96x | 12.1% | 71.3% | 40.9 | Volatility began after the peak |
| 2023 | 162.3 | 12.7 | 7.8% | 17.2 | 1.35x | 7.2% | 72.9% | 42.8 | Semiconductor correction |
| 2024 | 201.0 | 22.7 | 11.3% | 30.1 | 1.33x | 11.8% | 71.1% | 56.4 | Clear recovery |
| 2025 | 237.0 | 33.3 | 14.1% | 35.2 | 1.06x | 15.6% | 67.9% | 69.2 | Record high, but includes one-off factors |
Over the long term, Tokyo Ohka Kogyo’s 2021-2025 revenue CAGR was about 14.1%, while profit attributable to owners had a CAGR of about 17.1%. More importantly, the company remained profitable and generated positive operating cash flow during the 2023 industry pullback, then recovered quickly and reached new highs in 2024-2025. This shows the typical features of a high-quality materials supplier: it fluctuates, but it is not a fragile model whose cash flow breaks as soon as the cycle turns down.
On profit quality, I lean positive, with a haircut. The positive side is that over the past five years, operating cash flow broadly matched or even slightly exceeded net profit, and CFO/net profit was mostly above 1x. At the end of 2025, cash and cash equivalents were ¥69.2bn, book cash and deposits were ¥71.0bn, while interest-bearing debt totaled only about ¥26.5bn, leaving the company still in a net cash position. The negative side is that 2025 operating profit improvement included about ¥2.0bn of one-off gains, while net profit was also affected by nonrecurring gains related to the equipment business transfer. Simply extrapolating the 2025 margin for ten years would be clearly unsafe.
Free cash flow is the most important and easiest-to-misread point here. Using a definition closer to cash flow, 2025 operating cash flow was ¥35.2bn, while cash purchases of property, plant, equipment, and intangible assets totaled about ¥25.4bn, implying cash free cash flow of about ¥9.8bn. In 2024, the comparable figure was about ¥4.6bn. Compared with accounting profits of ¥22.7bn/¥33.3bn, this is clearly low, showing that the company remains in a heavy investment and capacity expansion phase. These are not “fake profits.” Rather, a meaningful portion of real cash earnings is being absorbed by growth investment and working capital.
Working capital confirms this point. At the end of 2025, accounts receivable rose from ¥41.8bn to ¥47.2bn, total inventories increased from about ¥36.9bn to ¥43.0bn, and accounts payable rose from ¥26.9bn to ¥29.5bn. Roughly speaking, the increase in trade receivables and inventory was clearly faster than the offset from trade payables, meaning growth is consuming cash. This is not necessarily bad, but it reminds us that Tokyo Ohka Kogyo is not a business where all profits can immediately be distributed to shareholders.
On capex intensity, 2025 capex was ¥28.7bn, far above depreciation of ¥8.8bn, and the 2026 plan rises further to ¥35.8bn. This means the current high growth is tied to front-loaded strengthening of manufacturing capital, not purely asset-light organic expansion. The benefit is that if these investments succeed, they can create larger capacity and stronger customer stickiness in the future. The drawback is that if industry demand or the company’s share falls short of expectations, capital payback periods will lengthen significantly.
On share count, note that the company completed a 1-for-3 stock split in January 2024, and EPS, BPS, and other figures in the securities report have been retroactively adjusted for the split. More worth noting is that at the end of 2025, the company held 7.922 million treasury shares, representing about 6.2% of issued shares. From an owner’s perspective, the stock split is irrelevant. Treasury shares and the pace of buybacks matter. Tokyo Ohka Kogyo’s recent buybacks occurred at levels far below the current price, which is a positive.
On accounting risk, I do not see obvious red flags for aggressive accounting or financial fraud. The company clearly discloses inventory write-down losses, one-off gains, profit drivers, major risks, and nonrecurring items, and its auditor is Deloitte Tohmatsu LLC. But I would stress that “no obvious red flags observed” is not the same as “no issue exists at a forensic level.” Making that distinction is more responsible than drawing a careless conclusion. Overall, I would characterize Tokyo Ohka Kogyo’s financial quality as: strong profits, strong cash flow, and a strong balance sheet, but during the expansion phase, free cash flow looks weaker than the income statement suggests.
Owner Earnings and Intrinsic Value
I care more about Tokyo Ohka Kogyo’s Owner Earnings than its PE alone. The company is in a clear expansion phase, so focusing only on accounting net profit can easily overstate the cash that can truly be distributed to owners. The FY2025 starting data are: profit attributable to owners of ¥33.3bn and depreciation of about ¥8.8bn. If the 2025 increase in trade working capital of about ¥9.8bn is treated as a cash outflow, and some maintenance capex is deducted, true distributable cash flow would be much lower than net profit.
The biggest difficulty is that maintenance capex is not separately disclosed by the company, so assumptions are required. I use three layers. Conservative case: treat maintenance capex as about ¥12bn and treat most of the 2025 working capital increase as real cash consumption, putting Owner Earnings around ¥20bn. Base case: assume a significant part of the 2025 working capital increase was temporary growth-related use and does not repeat every year over the long term, estimating Owner Earnings as CFO minus maintenance capex, or about ¥25bn. More optimistic case: maintenance capex is closer to depreciation, allowing Owner Earnings to reach ¥27-28bn. This means the current share price corresponds to P/Owner Earnings of roughly 41x-58x, which is not cheap. That multiple is the central evidence behind my view that the current price lacks a margin of safety.
First, look at Method 1: owner earnings discounted cash flow. My model assumptions are as follows:
Conservative scenario: starting OE ¥22bn, average annual growth of 6% over the next 10 years, discount rate of 9.5%, terminal growth of 1.5%;
Base scenario: starting OE ¥25bn, average annual growth of 8% over the next 10 years, discount rate of 8.0%, terminal growth of 2.0%;
Optimistic scenario: starting OE ¥28bn, average annual growth of 10% over the next 10 years, discount rate of 7.0%, terminal growth of 2.5%. In addition, I add back the company’s net cash of about ¥42.7bn at the end of 2025 separately. Under these assumptions, I get approximate per-share value centers of ¥3,600 in the conservative case, ¥6,000 in the base case, and ¥10,100 in the optimistic case. To avoid false precision, I would rather express the result as ranges: conservative ¥3,500-4,500; reasonable ¥5,500-6,500; optimistic ¥8,500-10,000. At the current ¥9,700, the market has already priced in an outcome fairly close to the optimistic scenario.
Next, look at Method 2: relative valuation. For Tokyo Ohka Kogyo itself, using the current price and FY2025 data, the stock trades at roughly 34.9x PE, 5.1x PB, and about 20x EV/EBITDA. Compared with tradable large Japanese chemical and materials peers, Google Finance search results show Shin-Etsu Chemical at about 27.0x PE, Fujifilm at about 15.1x, and Sumitomo Chemical at about 14.7x. Resonac’s PE is distorted by cyclicality and the profit base, reaching 80x+, so it is not a suitable normal anchor. Tokyo Ohka Kogyo deserves a premium to Fujifilm and Sumitomo Chemical, but explaining its current large premium to Shin-Etsu and Fujifilm requires many years of stronger growth and higher-quality cash returns. Using FY2026 net profit guidance of ¥35bn as the anchor and applying 22x-28x PE gives about ¥6,400-8,200 per share. Using 2025 EBITDA of ¥56.2bn and 14x-18x EV/EBITDA gives about ¥6,900-8,800 per share. Both relative valuation approaches point to the same conclusion: the current price is not a cheap zone.
Finally, look at Method 3: asset/liquidation value. At the end of 2025, Tokyo Ohka Kogyo had total assets of ¥335.3bn, net assets of ¥242.3bn, cash equivalents of ¥69.2bn, investment securities of ¥31.9bn, land of ¥14.0bn, and total liabilities of ¥93.0bn. If you value it on an asset basis, you get more of a low-thousands-of-yen-per-share static asset floor, which is nowhere near enough to support the current trading price of almost ¥10,000. In other words, the market is buying not the assets, but the high-quality cash flows that technology and customer relationships may produce over the next decade. That is reasonable, but it also means that if the growth narrative disappoints, valuation compression will hurt.
Combining the three methods, my conclusion is:
Conservative intrinsic value range: ¥3,500-5,000
Reasonable intrinsic value range: ¥5,500-7,500
Optimistic intrinsic value range: ¥8,500-10,000
This implies that the current ¥9,700 is roughly a 47%-76% premium to my reasonable intrinsic value, and sits near the upper end of the optimistic intrinsic value range. For conservative value investors with holding periods of more than ten years, I believe the required margin of safety should be at least 25%-30%. Therefore, I would place the ideal buy range at ¥4,000-5,000. The acceptable holding range is roughly ¥5,500-8,000. Above ¥9,000, I would view the stock as clearly expensive. This is why I describe it as “a good company, but not a good price today.”
Risks, Bear Case, and Opportunity Comparison
The most important risk for Tokyo Ohka Kogyo is not short-term share price volatility. It is paying a high price and then finding that future cash flows fail to meet the market’s optimistic expectations. This kind of permanent capital loss usually comes from several variables combining. First, competitive risk, including share erosion from Shin-Etsu, JSR, Fujifilm-related players, and new platform materials. Second, technology substitution risk, especially if the company chooses the wrong next-generation lithography materials path after EUV, which would quickly narrow the moat. Third, customer concentration risk: TSMC accounts for about one-third of revenue, and Taiwan accounts for more than one-third, so any key customer share change, qualification issue, or regional event would significantly affect results. Fourth, supply-chain and raw-material risk: the company itself lists raw material supply disruptions, price increases, and geopolitics as key risks. Fifth, regulatory and environmental risk, including chemical regulation, export restrictions, and compliance with local rules. Sixth, foreign exchange risk, since the company has deep overseas sales and manufacturing presence. Seventh, valuation compression risk, which is the most immediate risk today.
The strongest bear case is simple: Tokyo Ohka Kogyo may be an excellent company, but the market is already pricing it as an AI materials leader with almost no room for error. If the heavy 2025-2027 capex program simply builds capacity near a cyclical peak; if growth in TSMC and advanced-node-related share slows; if commercialization of next-generation EUV resist trails expectations; or if advanced-packaging demand growth falls short of market enthusiasm, the company can still remain a good company while shareholder returns become unattractive because the entry price was too high. In particular, the current dividend yield is only about 0.74%, and even using 2026 dividend guidance of ¥80, it is only about 0.82%. Meanwhile, Japan’s 10-year government bond yield had risen to about 2.74% on 2026-06-09. On an owner earnings basis, Tokyo Ohka Kogyo’s current owner earnings yield is still below the neighborhood of that risk-free yield, which is not friendly to conservative investors.
What facts would directly overturn my investment view? I would watch five items. First, TSMC sales concentration falls significantly, and the cause is not customer diversification but share loss. Second, EUV, advanced packaging, and high-purity chemicals growth comes in materially below the company’s 2027 targets. Third, after a large increase in capex, there is still no visible release of free cash flow in 2027-2028. Fourth, the company moves from net cash to relatively high leverage or executes a large acquisition at a high premium. Fifth, management starts emphasizing scale, revenue, and market narratives more than per-share value and cash returns. If these occur, I would be quicker than the market to admit that the stock was bought too expensively, or that the thesis was wrong.
Comparing Tokyo Ohka Kogyo with other opportunities leads me to a restrained answer. Compared with Shin-Etsu Chemical, the strongest tradable competitor, Tokyo Ohka Kogyo is more focused and has greater elasticity, but Shin-Etsu is larger, more diversified, and currently has a lower public-market PE. Compared with the TOPIX index, Tokyo Ohka Kogyo’s total shareholder return over the past five years was 252.4%, higher than TOPIX including dividends at 213.2%, showing that it did beat the index historically. But an excellent past does not guarantee excess return at the current price. Compared with Japan’s 10-year government bond, Tokyo Ohka Kogyo does not offer a superior immediate cash return to new buyers today, so it must rely on sustained multi-year growth to compensate. After this comparison, my judgment is: Tokyo Ohka Kogyo is clearly above the index average on company quality, but on current risk-reward, it is not clearly superior to a low-cost index ETF or higher-grade bonds/risk-free assets. If I could hold only 5 assets, I would not put it into the portfolio at today’s price. If the price returned to my ideal range, it would qualify for the candidate list.
Checklist and Final Conclusion
The checklist below is not a list of facts. It is a summary of investment judgments based on the evidence above.
| Check Item | Conclusion | Brief Explanation |
|---|---|---|
| Can I understand this business? | Pass | Clear economic model: high-end semiconductor materials + customer qualification + global localization |
| Does it have long-term stable demand? | Pass | Long-term semiconductor demand trends upward, but cyclicality cannot be ignored |
| Does it have a durable moat? | Pass | Mainly from qualification barriers, process know-how, manufacturing consistency, and customer relationships |
| Does it have pricing power? | Pass | But only moderately strong, not absolute bargaining power |
| Can it generate stable free cash flow? | Uncertain | Operating cash flow is strong, but FCF is clearly compressed during the expansion phase |
| Are its returns on capital excellent? | Pass | ROE has been good over time and reached 15.6% in 2025 |
| Is management trustworthy? | Pass | Basically candid, governance has improved, and buyback timing has been acceptable |
| Is capital allocation rational? | Pass | But M&A and heavy capex still require continued validation |
| Is the balance sheet robust? | Pass | Net cash and high equity ratio |
| Is valuation below intrinsic value? | Fail | Current price is above my reasonable range |
| Is the margin of safety sufficient? | Fail | Current price is closer to the optimistic scenario than the conservative scenario |
| Am I comfortable holding it long term? | Uncertain | The business is reassuring; the price is not |
| What key facts would make me sell? | Defined | Share loss, no FCF release, higher leverage, uncontrolled M&A |
| Do I want to buy only because the share price has risen or market sentiment is strong? | Probably yes | The current AI/advanced-node narrative is already hot, and valuation has expanded meaningfully |
【Final Rating】 Watch
【One-Sentence Investment Thesis】 Tokyo Ohka Kogyo is a high-quality semiconductor materials company that I would be willing to track for the long term and own at the right price, but at the current price of roughly ¥9,700, the market has already prepaid for too much optimism.
【Core Bull Case】
The company is one of the important global leaders in photoresists and related semiconductor materials, with deep technical and customer qualification barriers, while continuing to strengthen its EUV materials portfolio.
FY2025 fundamentals were very strong, with revenue, operating profit, profit attributable to owners, EBITDA, and ROE all reaching record highs.
The balance sheet is solid. The company was still in a net cash position at the end of 2025, supporting simultaneous capacity expansion, R&D, dividends, and buybacks.
Management’s buybacks generally occurred far below the current price, and the DOE 4% shareholder return framework is also fairly clear.
Advanced packaging, high-purity chemicals, and AI-related semiconductor demand provide growth handles for the next several years.
【Core Bear Case】
The current price implies about 34.9x FY2025 PE and about 5.1x PB, and looks clearly expensive versus owner earnings.
2025 profit included one-off inventory recognition gains and nonrecurring gains, so that year’s margin cannot simply be extrapolated.
TSMC accounts for about 33.6% of revenue and Taiwan for about 36.1%, meaning customer and regional concentration is high.
High capex and working capital absorption make distributable cash flow meaningfully lower than accounting net profit.
Competitors are also increasing local R&D and capacity investment, so the moat must keep widening rather than merely exist statically.
【Key Assumptions】
AI-driven advanced-node and advanced-packaging demand can remain strong for at least 3-5 more years.
Tokyo Ohka Kogyo’s share in EUV, KrF, advanced packaging, and high-purity chemicals is not significantly eroded.
The heavy 2025-2027 capex can convert into higher free cash flow after 2027, instead of only creating a larger asset burden.
Management maintains its current relatively rational discipline in shareholder returns and capital allocation.
【Fair Buy Price】 I would place the ideal buy range at ¥4,000-5,000. If I must give a range that is “acceptable but not exciting,” it would be roughly ¥5,500-7,000. The basis is that my base-case DCF lands near ¥6,000, relative valuation gives a range of roughly ¥6,400-8,800, and I want at least a 25%-30% margin of safety for a business with both cyclicality and technology risk.
【Target Holding Period】 If the future price is appropriate and the thesis remains intact, I think it is suitable for holding for more than 10 years. The precondition is that you do not pay for the next ten years of good news all at once when you buy.
【Expected Annualized Return】 Starting from the current price, my more conservative estimate is: 0%-2% in the conservative scenario, 4%-6% in the base scenario, and 8%-10% in the optimistic scenario. The core meaning of this range is not “money cannot be made.” It is that buying at today’s price makes it hard to obtain the high-certainty, high-odds return that traditional value investors prefer.
【Maximum Drawdown Risk】 If advanced-node or advanced-packaging demand falls short of expectations, customer concentration causes share volatility, capacity expansion fails to turn into cash flow, and the market compresses valuation from current growth-stock pricing back toward a more ordinary materials-stock range, a 40%-60% share price drawdown is not unimaginable. This is not the most likely scenario, but it is a permanent capital loss scenario that must be taken seriously.
【Tracking Indicators】
TSMC sales share and Taiwan revenue share
Revenue growth in EUV, advanced packaging, and high-purity chemicals
Operating cash flow, capex, and the pace of real free cash flow release
Delivery against 2026-2027 EBITDA and operating profit targets
Raw material prices and changes in working capital absorption
Net cash/net debt position
Whether buyback price and scale remain rational
Commercialization progress of new acquisitions and joint development projects
Share of one-off gains in profit
Competitors’ localization investment pace in Taiwan, South Korea, and Japan
【Signals That Would Trigger Reassessment】
Clear share loss at TSMC or advanced-node customers
No visible improvement in free cash flow around 2027
Large high-priced acquisition or clear leverage increase
Falling behind in EUV or next-generation photoresist roadmaps, or commercialization failure
Management narrative shifts too far toward “market size” and “scale,” while de-emphasizing per-share value and cash returns
【Final Recommendation】 Put calmly, Tokyo Ohka Kogyo currently looks most like a high-quality watchlist stock worth patiently waiting for, rather than a cheap stock that needs to be bought immediately. For long-term business owners, this company passes most commercial and governance tests of “is this something I would want to own for a long time,” but it does not pass the test of “does today’s price give me enough margin of safety.” My recommendation is not a rejection of the company. It is a rejection of rushed action at the current price.
This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.
Full report
Sign in to read the full report
Sign up free to unlock the full text, the Baillie growth scorecard, and full-text search.
Log in / Sign up free